SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Alexza(ALXA)-No Pain! Big Gain!!!!!
ALXA 0.9350.0%Jun 21 4:00 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Arthur Radley3/23/2007 9:52:59 PM
  Read Replies (1) of 26
 
The wait is over....hope for the best!! Rarely do you see a biotech release data for two separate trials on the same day.



Press Release Source: Alexza Pharmaceuticals, Inc.

Alexza to Release Top-Line Results from AZ-001 Phase IIb and AZ-004 Phase IIa Clinical Trials
Friday March 23, 5:53 pm ET
Conference Call to be Held on Monday, March 26, 2007

PALO ALTO, Calif., March 23 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA - News) announced today that it will host a conference call on Monday, March 26, 2007 at 8:30 a.m. Eastern Time. The purpose of the conference call is to provide top-line results from two clinical trials: a Phase IIb study with AZ-001 (Staccato® prochlorperazine), which is being developed to treat migraine headaches and a Phase IIa study with AZ-004 (Staccato loxapine), which is being developed to acutely treat agitation in patients with schizophrenia. A replay of the call will be available for two weeks following the event. The conference call, replay and webcast are open to all interested parties.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext